Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$3.5 - $4.5 $329,080 - $423,103
-94,023 Reduced 30.87%
210,582 $764,000
Q2 2021

Aug 16, 2021

BUY
$3.09 - $4.54 $3,760 - $5,525
1,217 Added 0.4%
304,605 $1.32 Million
Q1 2021

May 14, 2021

SELL
$3.35 - $4.93 $8,140 - $11,979
-2,430 Reduced 0.79%
303,388 $1.04 Million
Q4 2020

Mar 01, 2021

BUY
$2.35 - $3.74 $495,539 - $788,646
210,868 Added 222.08%
305,818 $1.07 Million
Q3 2020

Nov 13, 2020

SELL
$1.78 - $4.13 $20,925 - $48,552
-11,756 Reduced 11.02%
94,950 $227,000
Q2 2020

Aug 14, 2020

SELL
$1.41 - $2.05 $2,749 - $3,997
-1,950 Reduced 1.79%
106,706 $195,000
Q1 2020

May 15, 2020

BUY
$1.27 - $3.0 $26,137 - $61,743
20,581 Added 23.37%
108,656 $169,000
Q4 2019

Feb 14, 2020

SELL
$1.6 - $2.43 $9,286 - $14,103
-5,804 Reduced 6.18%
88,075 $188,000
Q3 2019

Nov 14, 2019

BUY
$1.63 - $2.62 $18,125 - $29,134
11,120 Added 13.44%
93,879 $175,000
Q2 2019

Aug 15, 2019

BUY
$2.02 - $2.61 $46,062 - $59,515
22,803 Added 38.03%
82,759 $0
Q2 2018

Aug 14, 2018

SELL
$2.83 - $4.11 $15,641 - $22,715
-5,527 Reduced 8.44%
59,956 $0
Q1 2018

May 14, 2018

BUY
$3.54 - $4.54 $136,229 - $174,712
38,483 Added 142.53%
65,483 $0
Q4 2017

Feb 09, 2018

BUY
$3.23 - $4.3 $87,210 - $116,100
27,000
27,000 $0

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.